AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Business Editors & Health/Medical Writers
BILLERICA, Mass. & FOSTER CITY, Calif.--(BW HealthWire)--June 7, 2001
Will Make MALDI-TOF Intellectual Property Available for Licensing
Bruker Daltonics Inc. (NASDAQ: BDAL), Applied Biosystems Group (NYSE: ABI), an Applera Corporation business, and Indiana University's Advanced Research & Technology Institute (IU-ARTI), the technology transfer arm of Indiana University, today announced an agreement for the licensing of a portfolio of significant mass spectrometry patents. As part of the agreement, Bruker Daltonics has been appointed the exclusive agent for licensing this combined intellectual property to the life-science industry. Financial terms of the agreement were not disclosed.
These patent portfolios relate to MALDI-TOF mass spectrometry and cover the significant technology called Space-Velocity Correlation Focusing (SVCF), or Delayed Extraction (DE). …
Source: HighBeam Research, Bruker Daltonics, Applied Biosystems and Indiana University Cross...